Source: http://www.google.ca/patents/US7645442
Timestamp: 2015-11-29 03:28:46
Document Index: 243972817

Matched Legal Cases: ['Application No. 60', 'Application No. 60', 'Application No. 60', 'Application No. 60', 'Application No. 60', 'Application No. 60', 'Application No. 60', 'Application No. 60', 'Application No. 60']

Patent US7645442 - Rapid-heating drug delivery article and method of use - Google PatentsSearch Images Maps Play YouTube News Gmail Drive More »Sign inAdvanced Patent SearchPatentsA device, method, and system for producing a condensation aerosol are disclosed. The device includes a chamber having an upstream opening and a downstream opening which allow gas to flow through the chamber, and a heat-conductive substrate located at a position between the upstream and downstream openings....http://www.google.ca/patents/US7645442?utm_source=gb-gplus-sharePatent US7645442 - Rapid-heating drug delivery article and method of useAdvanced Patent SearchPublication numberUS7645442 B2Publication typeGrantApplication numberUS 10/633,876Publication date12 Jan 2010Filing date4 Aug 2003Priority date24 May 2001Fee statusPaidAlso published asUS20070028916Publication number10633876, 633876, US 7645442 B2, US 7645442B2, US-B2-7645442, US7645442 B2, US7645442B2InventorsRon L. Hale, Peter M. Lloyd, Amy Lu, Daniel J. Myers, Reynaldo J. Quintana, Joshua D. Rabinowitz, Dennis W. Solas, Soonho Song, Curtis Tom, Martin J. WensleyOriginal AssigneeAlexza Pharmaceuticals, Inc.Export CitationBiBTeX, EndNote, RefManPatent Citations (544), Non-Patent Citations (125), Referenced by (19), Classifications (33), Legal Events (4) External Links: USPTO, USPTO Assignment, EspacenetRapid-heating drug delivery article and method of use
US 7645442 B2Abstract
A device, method, and system for producing a condensation aerosol are disclosed. The device includes a chamber having an upstream opening and a downstream opening which allow gas to flow through the chamber, and a heat-conductive substrate located at a position between the upstream and downstream openings. Formed on the substrate is a drug composition film containing a therapeutically effective dose of a drug when the drug is administered in aerosol form. A heat source in the device is operable to supply heat to the substrate to produce a substrate temperature greater than 300� C., and to substantially volatilize the drug composition film from the substrate in a period of 2 seconds or less. The device produces an aerosol containing less than about 10% by weight drug composition degradation products and at least 50% of the drug composition of said film.
1. A device for producing a condensation aerosol comprising
(a) a chamber comprising an upstream opening and a downstream opening, the openings allowing gas to flow therethrough
(b) a heat-conductive substrate, the substrate located at a position between the upstream and downstream openings,
(c) a drug composition film on the substrate, the film comprising a therapeutically effective dose of a drug when the drug is administered in aerosol form
(d) a heat source for supplying heat to said substrate to produce a substrate temperature greater than 300� C., and to substantially volatilize the drug composition film from the substrate in a period of 2 seconds or less, and
(e) means for producing an air flow across the substrate producing aerosol particles by condensation,
wherein the device produces a condensation aerosol containing about 10% or less by weight drug composition degradation products and at least 50% of the drug composition of said film.
2. The device of claim 1, further comprising a mechanism for initiating said heat source.
3. The device of claim 1, wherein said substrate has an impermeable surface.
4. The device of claim 1, wherein said substrate has a contiguous surface area of greater than 1 mm2 and a material density of greater than 0.5 g/cc.
5. The device of claim 1, wherein the film has a thickness between 0.05 and 20 microns.
6. The device of claim 5, wherein the thickness of the film is selected to allow the drug composition to volatilize from the substrate with about 5% or less by weight drug composition degradation products.
7. The device of claim 6, wherein the drug composition is one that when vaporized from a film on an impermeable surface of a heat conductive substrate, the aerosol exhibits an increasing level of drug composition degradation products with increasing film thicknesses.
8. The device of claim 5, wherein said drug composition comprises a drug selected from the group consisting of the following, and a film thickness within the range disclosed for said drug:
(32) valdecoxib, film thickness between 0.5 and 10 μm;
9. The device of claim 1, wherein said heat source substantially volatilizes the drug composition film from the substrate within a period of less than 0.5 seconds.
10. The device of claim 1, wherein said heat source comprises an ignitable solid chemical fuel disposed adjacent to an interior surface of the substrate, wherein the ignition of said fuel is effective to vaporize the drug composition film.
11. The device of claim 1, wherein said heat source for supplying heat to said substrate produces a substrate temperature greater than 350� C.
12. A method for producing a condensation aerosol comprising (a) heating to a temperature greater than 300� C. a heat-conductive substrate having a drug composition film on the surface, the film comprising a therapeutically effective dose of a drug when the drug is administered in aerosol form;
(b) substantially volatilizing the drug composition film from the substrate in a period of 2 seconds or less, and
(c) flowing air across the volatilized drug composition, under conditions to produce a condensation aerosol containing less than 10% by weight drug composition degradation products and at least 50% of the drug composition in said film.
13. The method of claim 12, wherein said substrate has an impermeable surface.
14. The method of claim 12, wherein said substrate has a contiguous surface area of greater than 1 mm2 and a material density of greater than 0.5 g/cc.
15. The method of claim 12, wherein the film has a thickness between 0.05 and 20 microns.
16. The method of claim 15, wherein the thickness of the film is selected to allow the drug composition to volatilize from the substrate with about 10% or less by weight drug composition degradation products.
17. The method of claim 16, wherein the drug composition is one that when vaporized from a film on an impermeable surface of a heat conductive substrate, the aerosol exhibits an increasing level of drug composition degradation products with increasing film thicknesses.
18. The method of claim 12, wherein said drug composition comprises a drug selected from the group consisting of the following, and a film thickness within the range disclosed for said drug:
19. The method of claim 12, wherein said substantially volatilizing the film is complete within a period of less than 0.5 seconds.
(a) a heat-conductive substrate having an interior surface and an exterior surface;
(b) a drug composition film on the substrate exterior surface, the film comprising a therapeutically effective dose of a drug when the drug is administered in aerosol form, and
(c) a heat source for supplying heat to said substrate to produce a substrate temperature greater than 300� C. and to substantially volatilize the drug composition film from the substrate in a period of 2 seconds or less wherein the device produces a condensation aerosol containing about 10% or less by weight drug composition degradation products and at least 50% of the drug composition of said film.
21. The assembly of claim 20, wherein said substrate has an impermeable surface.
22. The assembly of claim 20, wherein said substrate surface has a contiguous surface area of greater than 1 mm2 and a material density of greater than 0.5 g/cc.
23. The assembly of claim 20, wherein the film has a thickness between 0.05 and 20 microns.
24. The assembly of claim 23, wherein the thickness of the film is selected to allow the drug composition to volatilize from the substrate with about 5% or less by weight drug composition degradation products.
25. The assembly of claim 24, the drug composition is one that when vaporized from a film on an impermeable surface of a heat conductive substrate, the aerosol exhibits an increasing level of drug composition degradation products with increasing film thickness.
26. The assembly of claim 20, wherein said drug composition comprises a drug selected from the group consisting of the following, and a film thickness within the range disclosed for said drug:
27. The assembly of claim 20, wherein said heat source substantially volatilizes the drug composition film from the substrate within a period of less than 0.5 seconds.
28. The device of claim 20, wherein said heat source comprises an ignitable solid chemical fuel disposed adjacent to the interior surface of the substrate, wherein the ignition of said fuel is effective to vaporize the drug composition film.
This application is also a continuation-in-part of application Ser. No. 10/057,198, filed Oct. 26, 2001, which claims benefit of Provisional Application No. 60/296,225, filed. Jun. 5, 2001.
This application is also a continuation-in-part of application Ser. No. 10/146,080, filed May 13, 2002, which is a continuation-in-part of application Ser. No. 10/057,198, filed Oct. 26, 2001, which claims the benefit of Provisional Application No. 60/296,225, filed Jun. 5, 2001. This Application is also a continuation-in-part of application Ser. No. 10/057,197, filed Oct. 26, 2001, which claims the benefit of Provisional Application No. 60/296,225, filed. Jun. 5, 2001.
This application is also a continuation-in-part of application Ser. No. 10/146,088, filed May 13, 2002, which is a continuation-in-part of patent application Ser. No. 10/057,198, filed Oct. 26, 2001, which claims the benefit of Provisional Application No. 60/296,225, filed Jun. 5, 2001. This application is also a continuation-in-part of patent application Ser. No. 10/057,197, filed Oct. 26, 2001, which claims the benefit of Provisional Application No. 60/296,225, filed Jun. 5, 2001.
This application is also a continuation-in-part of application Ser. No. 10/146,515, filed May 13, 2002 now U.S. Pat. No. 6,682,716, which is a continuation-in-part of patent application Ser. No. 10/057,198, filed Oct. 26, 2001, which claims the benefit of Provisional Application No. 60/296,225, filed Jun. 5, 2001. This application is also a continuation-in-part of patent application Ser. No. 10/057,197, filed Oct. 26, 2001, which claims the benefit of Provisional Application No. 60/296,225, filed Jun. 5, 2001.
This application is also a continuation-in-part of application Ser. No. 10/146,516, filed May 13, 2002 now U.S. Pat. No. 6,737,042, which claims the benefit of Provisional Application No. 60/294,203, filed May 24, 2001, and also claims the benefit of Provisional Application No. 60/317,479, filed Sep. 5, 2001.
This application is also a continuation-in-part of a